相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Response to lenalidomide in myelodysplastic syndromes with del(5q): influence of cytogenetics and mutations
Mar Mallo et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
A novel hierarchical prognostic model of AML solely based on molecular mutations
Vera Grossmann et al.
BLOOD (2012)
Different boundaries characterize isolated and non-isolated 5q deletions in myelodysplastic syndromes and acute myeloid leukemias
Valeria Nofrini et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
New Comprehensive Cytogenetic Scoring System for Primary Myelodysplastic Syndromes (MDS) and Oligoblastic Acute Myeloid Leukemia After MDS Derived From an International Database Merge
Julie Schanz et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Topography, Clinical, and Genomic Correlates of 5q Myeloid Malignancies Revisited
Andres Jerez et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Molecular characterization of deletions of the long arm of chromosome 5 (del(5q)) in 94 MDS/AML patients
N. Douet-Guilbert et al.
LEUKEMIA (2012)
TP53 Mutations in Low-Risk Myelodysplastic Syndromes With del(5q) Predict Disease Progression
Martin Jaedersten et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Impact of adjunct cytogenetic abnormalities for prognostic stratification in patients with myelodysplastic syndrome and deletion 5q
M. Mallo et al.
LEUKEMIA (2011)
Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials
David Grimwade et al.
BLOOD (2010)
Implementation of standardized international karyotype scoring practices is needed to provide uniform and systematic evaluation for patients with myelodysplastic syndrome using IPSS criteria: An International Working Group on MDS Cytogenetics Study
Kathy Chun et al.
LEUKEMIA RESEARCH (2010)
NPM1 Deletion Is Associated with Gross Chromosomal Rearrangements in Leukemia
Roberta La Starza et al.
PLOS ONE (2010)
Deletion 5q in myelodysplastic syndrome: a paradigm for the study of hemizygous deletions in cancer
B. L. Ebert
LEUKEMIA (2009)
Genetics of therapy-related myelodysplasia and acute myeloid leukemia
J. Pedersen-Bjergaard et al.
LEUKEMIA (2008)
Guidance for fluorescence in situ hybridization testing in hematologic disorders
Daynna J. Wolff et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2007)
Alternative genetic pathways and cooperating genetic abnormalities in the pathogenesis of therapy-related myelodysplasia and acute myeloid leukemia
J. Pedersen-Bjergaard et al.
LEUKEMIA (2006)
Loss of genetic material is more common than gain in acute myeloid leukemia with complex aberrant karyotype:: A detailed analysis of 125 cases using conventional chromosome analysis and fluorescence in situ hybridization including 24-color FISH
C Schoch et al.
GENES CHROMOSOMES & CANCER (2002)
Myeloid disorders with deletion of 5q as the sole karyotypic abnormality: The clinical and pathologic spectrum
LT Washington et al.
LEUKEMIA & LYMPHOMA (2002)
Comparison of chromosome banding analysis, interphase- and hypermetaphase-FISH, qualitative and quantitative PCR for diagnosis and for follow-up in chronic myeloid leukemia: a study on 350 cases
C Schoch et al.
LEUKEMIA (2002)
分享论文
